Spark Biomedical Awarded 115M Department of Defense Phase II STTR Grant in Partnership with Battelle Memorial Institute

DALLAS, Texas, Aug. 29, 2023 (GLOBE NEWSWIRE) — Aug. 29, 2023 — Spark Biomedical, Inc., a Dallas-based pioneer in wearable neurostimulation technology, was awarded a $1.15M Phase II grant to develop a Transcutaneous Auricular Neurostimulation (tAN®) device, Sparrow® Hawk, to address the adverse effects of acute stress reaction (ASR). In…Read More